MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/thoraxjnl-2015-208138

Медицинская библиотека · Thorax · 2016

Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.

Loymans Rik J B, Honkoop Persijn J, Termeer Evelien H, Snoeck-Stroband Jiska B, Assendelft Willem J J, Schermer Tjard R J, Chung Kian Fan, Sousa Ana R, Sterk Peter J, Reddel Helen K, Sont Jacob K, Ter Riet Gerben

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАPragmatic Clinical TrialПеревод в очереди

Аннотация

BACKGROUND

Preventing exacerbations of asthma is a major goal in current guidelines. We aimed to develop a prediction model enabling practitioners to identify patients at risk of severe exacerbations who could potentially benefit from a change in management.

METHODS

We used data from a 12-month primary care pragmatic trial; candidate predictors were identified from GINA 2014 and selected with a multivariable bootstrapping procedure. Three models were constructed, based on: (1) history, (2) history+spirometry and (3) history+spirometry+FeNO. Final models were corrected for overoptimism by shrinking the regression coefficients; predictive performance was assessed by the area under the receiver operating characteristic curve (AUROC) and Hosmer-Lemeshow test. Models were externally validated in a data set including patients with severe asthma (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes).

RESULTS

80/611 (13.1%) participants experienced ≥1 severe exacerbation. Five predictors (Asthma Control Questionnaire score, current smoking, chronic sinusitis, previous hospital admission for asthma and ≥1 severe exacerbation in the previous year) were retained in the history model (AUROC 0.77 (95% CI 0.75 to 0.80); Hosmer-Lemeshow p value 0.35). Adding spirometry and FeNO subsequently improved discrimination slightly (AUROC 0.79 (95% CI 0.77 to 0.81) and 0.80 (95% CI 0.78 to 0.81), respectively). External validation yielded AUROCs of 0.69 (95% CI 0.63 to 0.75; 0.63 to 0.75 and 0.63 to 0.75) for the three models, respectively; calibration was best for the spirometry ­model.

CONCLUSIONS

A simple history-based model extended with spirometry identifies patients who are prone to asthma exacerbations. The additional value of FeNO is modest. These models merit an implementation study in clinical practice to assess their utility.

TRIAL REGISTRATION NUMBER: NTR 1756.

Для цитирования: Loymans Rik J B, Honkoop Persijn J, Termeer Evelien H, Snoeck-Stroband Jiska B, Assendelft Willem J J, Schermer Tjard R J, Chung Kian Fan, Sousa Ana R, Sterk Peter J, Reddel Helen K, Sont Jacob K, Ter Riet Gerben. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.. Thorax. 2016. DOI: 10.1136/thoraxjnl-2015-208138.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.